Skip Nav Destination
Issues
1 December 2002
ISSN 1078-0432
EISSN 1557-3265
Issue Sections
The Biology Behind
The Cooperative Group Bulletin Board
Testing of New Agents in Childhood Cancer Preclinical Models: Meeting Summary
Peter J. Houghton; Peter C. Adamson; Susan Blaney; Howard A. Fine; Richard Gorlick; Michelle Haber; Lee Helman; Steve Hirschfeld; Melinda G. Hollingshead; Mark A. Israel; Richard B. Lock; John M. Maris; Glenn Merlino; Wendy Patterson; C. Patrick Reynolds; Kevin Shannon; Alice Yu; John Yu; Malcolm A. Smith
Advances in Brief
Clinical Trials
Feasibility and Correlates of Arsenic Trioxide Combined with Ascorbic Acid-mediated Depletion of Intracellular Glutathione for the Treatment of Relapsed/Refractory Multiple Myeloma1
Nizar J. Bahlis; Jennifer McCafferty-Grad; Ileana Jordan-McMurry; Jim Neil; Isildinha Reis; Mohamed Kharfan-Dabaja; James Eckman; Mark Goodman; Hugo F. Fernandez; Lawrence H. Boise; Kelvin P. Lee
Molecular Oncology, Markers, Clinical Correlates
Regular Articles
Clinical Trials
Safety and Immunogenicity of TA-HPV, a Recombinant Vaccinia Virus Expressing Modified Human Papillomavirus (HPV)-16 and HPV-18 E6 and E7 Genes, in Women with Progressive Cervical Cancer1
Andreas M. Kaufmann; Peter L. Stern; Elaine M. Rankin; Harald Sommer; Volkmar Nuessler; Achim Schneider; Malcom Adams; Toli S. Onon; Thomas Bauknecht; Uwe Wagner; Karlijn Kroon; Julian Hickling; Christopher M. Boswell; Simon N. Stacey; Henry C. Kitchener; Jennifer Gillard; Jantien Wanders; John St. C. Roberts; Heinz Zwierzina
Phase I Study of Intraperitoneal Recombinant Human Interleukin 12 in Patients with Müllerian Carcinoma, Gastrointestinal Primary Malignancies, and Mesothelioma1
Renato Lenzi; Michael Rosenblum; Claire Verschraegen; Andrzej P. Kudelka; John J. Kavanagh; Marshall E. Hicks; Eric A. Lang; Michael A. Nash; Lawrence B. Levy; Michael E. Garcia; Chris D. Platsoucas; James L. Abbruzzese; Ralph S. Freedman
A Phase I Study of the Natural Killer T-Cell Ligand α-Galactosylceramide (KRN7000) in Patients with Solid Tumors
Giuseppe Giaccone; Cornelis J. A. Punt; Yoshitaka Ando; Rita Ruijter; Nobusuke Nishi; Marlies Peters; B. Mary E. von Blomberg; Rik J. Scheper; Hans J. J. van der Vliet; Alfons J. M. van den Eertwegh; Marja Roelvink; Jos Beijnen; Heinz Zwierzina; Herbert M. Pinedo
A Phase I Trial of a Potent P-Glycoprotein Inhibitor, Zosuquidar.3HCl Trihydrochloride (LY335979), Administered Orally in Combination with Doxorubicin in Patients with Advanced Malignancies
Eric H. Rubin; Dinesh P. de Alwis; Isabelle Pouliquen; Lisa Green; Phil Marder; Yong Lin; Rita Musanti; Stephanie L. Grospe; Sharon L. Smith; Deborah L. Toppmeyer; Judy Much; Michael Kane; Ajai Chaudhary; Christopher Jordan; Michael Burgess; Christopher A. Slapak
A Phase I Trial of Escalating Doses of Trastuzumab Combined with Daily Subcutaneous Interleukin 2: Report of Cancer and Leukemia Group B 96611
Gini F. Fleming; Neal J. Meropol; Gary L. Rosner; Donna R. Hollis; William E. Carson, III; Michael Caligiuri; Joanne Mortimer; Katherine Tkaczuk; Robin Parihar; Richard L. Schilsky; Mark J. Ratain
Research Articles
Molecular Oncology, Markers, Clinical Correlates
Rare Variants of ATM and Risk for Hodgkin’s Disease and Radiation-associated Breast Cancers1
Kenneth Offit; Shlomit Gilad; Shoshana Paglin; Prema Kolachana; Laila C. Roisman; Khedoudja Nafa; Vincent Yeugelewitz; Maria Gonzales; Mark Robson; Deborah McDermott; Heather Hanson Pierce; Noah D. Kauff; Paz Einat; Suresh Jhanwar; Jaya M. Satagopan; Carole Oddoux; Nathan Ellis; Rami Skaliter; Joachim Yahalom
Microvessel Density, Expression of Estrogen Receptor α, MIB-1, p53, and c-erbB-2 in Inflammatory Breast Cancer
Nicole J. McCarthy; Xiaowei Yang; Ilona R. Linnoila; Maria J. Merino; Stephen M. Hewitt; Allyson L. Parr; Soonmyung Paik; Seth M. Steinberg; Dan P. Hartmann; Nejib Mourali; Paul H. Levine; Sandra M. Swain
Experimental Therapeutics, Preclinical Pharmacology
Effectiveness of Ecteinascidin-743 against Drug-sensitive and -resistant Bone Tumor Cells1
Katia Scotlandi; Stefania Perdichizzi; Maria Cristina Manara; Massimo Serra; Stefania Benini; Vanessa Cerisano; Rosaria Strammiello; Mario Mercuri; Gemma Reverter-Branchat; Glynn Faircloth; Maurizio D’Incalci; Piero Picci
Pattern of Antitumor Activity of a Novel Camptothecin, ST1481, in a Large Panel of Human Tumor Xenografts1
Graziella Pratesi; Michelandrea De Cesare; Nives Carenini; Paola Perego; Sabina C. Righetti; Carla Cucco; Lucio Merlini; Claudio Pisano; Sergio Penco; Paolo Carminati; Loredana Vesci; Franco Zunino
Retraction
Acknowledgment to Reviewers
Advertisement
